Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Assiut University
Retrospective study aims to evaluate the effect of EGFR expression in metastatic colorectal cancer and the outcome of treatment with anti\_EGFR targeted therapy between left colon and rectal cancer
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1. age above 18
2. Both sex
3. Performance status zero to one according to ECOG scale system
4. Histo-pathologial diagnosis adenocarcinoma of left colon or rectum.
5. Patients diagnosed with left colon and rectal cancer.
6. Patients eligible to receive chemotherapy (with renal and liver chemistry, and normal CBC.
7. Patients diagnosed with metastatic stage.
8. K-RAS wild type.
You may not be if
1. Second malignancy
2. Histo-pathological types other than adenocarcinoma.
